Clinical Genomics Market

Clinical Genomics Market - Global Industry, Analysis, Size, Share, Growth, Trends, and Forecasts 2021-2031

Clinical Genomics Market - Overview

A genome is an organism's complete set of DNA contained in a single cell. Genomics is a subfield of genetics that studies the genetic analysis and perception of the genome of a living organism. Clinical genomics is the study of an organism's genetic makeup for diagnostic purposes such as cancer diagnosis, identifying pre-existing causes of potential disease, and customizing care regimens to a patient's needs. The advancement of molecular biology has transformed disease detection and treatment. Modern disease detection techniques based on RNA and DNA identification have several advantages over traditional methods. The increasing awareness about latest diagnostic approaches is projected to drive the sales growth of the global Clinical Genomics market during the forecast period set between 2021 and 2031.

The clinical genomics market is categorized on the basis of product type, application, test type, end user, and region. With respect to product type, the market is categorized into services, consumables and reagents, and instruments. Based on application, the market is grouped into prenatal screening, carrier screening, genetics, newborn screening, diagnostics, and others. In terms of test type, the market is categorized into biochemical tests, chromosomal tests, and molecular tests. By end user, the market is grouped into academic and research institutes, government laboratories and research centers, hospitals and clinics, and others.

The research report on the clinical genomics offers a 360-degree overview of the market and factors promoting or demoting its growth. This includes drivers, restraints, challenges, and future growth opportunities. List of the players operating in this market and their efforts to obtain a significant position in the market competition in terms of innovations and new product launches is also discussed in details. It also focuses on the recent developments and innovations that helped the market grow in terms of revenue generation. The impact of the novel COVID19 pandemic is also discussed in the report. For more information on the report, refer to the company website.

Clinical Genomics Market - Competitive Landscape

The nature of competition for this market is significantly competitive attributed to the presence of a handful of players. Leading players of the clinical genomics market are engaging in joint ventures and merger strategies to gain an upper hand in the overall market competition. Others are investing in introduction of innovative products to attract more revenues to the market. The key objective is to ensure a significant position in the market competition and earn handsome revenues for the overall market.

Some of the key players of the global Clinical Genomics market include:

  • Veritas Genetics
  • Strand Life Sciences Pvt. Ltd.
  • Rosetta Genomics Ltd.
  • Retrogen Inc.
  • Quest Diagnostics Incorporated
  • Personalis Inc.
  • PerkinElmer Inc.
  • Pathgroup
  • Opko Health Inc.
  • NeoGenomics Inc.
  • Natera Inc.
  • Myriad Genetics Inc.
  • MedGenome
  • Iverson Genetic Diagnostics Inc.
  • Invitae Corporation
  • Illumina Inc.
  • Genomic Health Inc.
  • Gene by Gene Ltd.
  • Foundation Medicine Inc.
  • Eurofins Scientific SE
  • Clinical Genomics Technologies Pty Ltd.
  • Centogene AG
  • Beijing Genomics Institute
  • Others

Clinical Genomics Market - Growth Drivers

The continuous investments in improvement of diagnostic and therapeutic purposes are projected to serve as key growth drivers promoting the growth of the global clinical genomics market. Besides this, improving healthcare facilities especially in the emerging nations and government support in the form of new diagnostic approaches will further help this market continue to witness lucrative growth opportunities in the near future.

Clinical Genomics Market - Geographical Insights

Geographically, this market is widespread into the regions of Latin America, Europe, North America, and the Middle East and Africa. These regions are further categorized as per the nations bringing business. North America and Europe emerged as the largest revenue generators for the clinical genomics market on account of the increasing expenditure on healthcare, coupled with the presence of well aware people about new diagnostic approaches. On the other side, Asia Pacific is projected to emerge as the fastest growing market for clinical genomics. This is attributed to the rapidly changing demographics, and rate of development of the medical sector. Increasing rate of reimbursement schemes supported by governments of the developing nations and increase in awareness programs about better diagnostic approaches will further help this region generate notable revenues in the coming years.


Copyright © Transparency Market Research, Inc. All Rights reserved